Tumor-specific expression of MicroRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathways

Molecular Therapy

Volumn 19, Issue 8, 2011, Pages 1521-1528

  Chen, Lizao ^a   Zheng, Jianming ^a   Zhang, Yan ^a   Yang, Luxi ^a   Wang, Jiaqi ^a   Ni, Jian ^b   Cui, Daxiang ^b   Yu, Chaoqin ^a   Cai, Zailong ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CYCLIN D2; CYCLIN E; CYCLIN E2; ESTROGEN RECEPTOR ALPHA; MICRORNA; MICRORNA 26A; PROGESTERONE RECEPTOR; PROTEIN P53; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN;

EID: 79961020784     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2011.64     Document Type: Article

References (33)

1. Colombo, M (1992). Hepatocellular carcinoma. J Hepatol 15: 225-236.
2. Bruix, J, Boix, L, Sala, M and Llovet, JM (2004). Focus on hepatocellular carcinoma. Cancer Cell 5: 215-219. (Pubitemid 38402113)
3. El-Serag, HB and Rudolph, KL (2007). Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576. (Pubitemid 46890874)
4. Francavilla, A, Polimeno, L, Barone, M, Azzarone, A and Starzl, TE (1993). Hepatic regeneration and growth factors. J Surg Oncol Suppl 3: 1-7. (Pubitemid 23179713)
5. Yager, JD Jr and Yager, R (1980). Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats. Cancer Res 40: 3680-3685. (Pubitemid 10003771)
6. Waalkes, MP, Liu, J, Chen, H, Xie, Y, Achanzar, WE, Zhou, YS et al. (2004). Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero. J Natl Cancer Inst 96: 466-474. (Pubitemid 38443650)
7. Ji, J, Shi, J, Budhu, A, Yu, Z, Forgues, M, Roessler, S et al. (2009). MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 361: 1437-1447.
8. Kota, J, Chivukula, RR, O'Donnell, KA, Wentzel, EA, Montgomery, CL, Hwang, HW et al. (2009). Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137: 1005-1017.
9. He, LF, Wang, YG, Xiao, T, Zhang, KJ, Li, GC, Gu, JF et al. (2009). Suppression of cancer growth in mice by adeno-associated virus vector-mediated IFN-β expression driven by hTERT promoter. Cancer Lett 286: 196-205.
10. Hirano, T, Kaneko, S, Kaneda, Y, Saito, I, Tamaoki, T, Furuyama, J et al. (2001). HVJ-liposome-mediated transfection of HSVtk gene driven by AFP promoter inhibits hepatic tumor growth of hepatocellular carcinoma in SCID mice. Gene Ther 8: 80-83. (Pubitemid 32162420)
11. Tomizawa, M, Saisho, H and Tagawa, M (2003). Regulatory regions of growthrelated genes can activate an exogenous gene of the α-fetoprotein promoter to a comparable degree in human hepatocellular carcinoma cells. Anticancer Res 23: 3273-3277. (Pubitemid 36975423)
12. Zivadinovic, D, Gametchu, B and Watson, CS (2005). Membrane estrogen receptor-α levels in MCF-7 breast cancer cells predict cAMP and proliferation responses. Breast Cancer Res 7: R101-R112.
13. Lo, R, Burgoon, L, Macpherson, L, Ahmed, S and Matthews, J (2010). Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells. Biochim Biophys Acta 1799: 469-479.
14. Wakeling, AE, Dukes, M and Bowler, J (1991). A potent specific pure antiestrogen with clinical potential. Cancer Res 51: 3867-3873.
15. Riaz, A, Ryu, RK, Kulik, LM, Mulcahy, MF, Lewandowski, RJ, Minocha, J et al. (2009). α-Fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survival. J Clin Oncol 27: 5734-5742.
16. Stroescu, C, Herlea, V, Dragnea, A and Popescu, I (2006). The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas. J Gastrointestin Liver Dis 15: 9-14. (Pubitemid 43845262)
17. Lewis, BP, Burge, CB and Bartel, DP (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20. (Pubitemid 40094598)
18. Shimizu, S, Takehara, T, Hikita, H, Kodama, T, Miyagi, T, Hosui, A et al. (2010). The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma. J Hepatol 52: 698-704.
19. Wang, B, Majumder, S, Nuovo, G, Kutay, H, Volinia, S, Patel, T et al. (2009). Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. Hepatology 50: 1152-1161.
20. Yang, Y, Li, Q, Ertl, HC and Wilson, JM (1995). Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 69: 2004-2015.
21. Gunter, KC, Khan, AS and Noguchi, PD (1993). The safety of retroviral vectors. Hum Gene Ther 4: 643-645. (Pubitemid 24305761)
22. Cavalli, R, Bisazza, A, Sessa, R, Primo, L, Fenili, F, Manfredi, A et al. (2010). Amphoteric agmatine containing polyamidoamines as carriers for plasmid DNA in vitro and in vivo delivery. Biomacromolecules 11: 2667-2674.
23. Davis, M, Portmann, B, Searle, M, Wright, R and Williams, R (1975). Histological evidence of carcinoma in a hepatic tumour associated with oral contraceptives. Br Med J 4: 496-498.
24. Annicotte, JS, Chavey, C, Servant, N, Teyssier, J, Bardin, A, Licznar, A et al. (2005). The nuclear receptor liver receptor homolog-1 is an estrogen receptor target gene. Oncogene 24: 8167-8175. (Pubitemid 41759815)
25. Zhao, YL, Han, WD, Li, Q, Mu, YM, Lu, XC, Yu, L et al. (2005). Mechanism of transcriptional regulation of LRP16 gene expression by 17-β estradiol in MCF-7 human breast cancer cells. J Mol Endocrinol 34: 77-89. (Pubitemid 40305551)
26. Eagon, PK, Francavilla, A, DiLeo, A, Elm, MS, Gennari, L, Mazzaferro, V et al. (1991). Quantitation of estrogen and androgen receptors in hepatocellular carcinoma and adjacent normal human liver. Dig Dis Sci 36: 1303-1308.
27. Nagasue, N, Yu, L, Yukaya, H, Kohno, H and Nakamura, T (1995). Androgen and oestrogen receptors in hepatocellular carcinoma and surrounding liver parenchyma: impact on intrahepatic recurrence after hepatic resection. Br J Surg 82: 542-547.
28. Dhasarathy, A, Kajita, M and Wade, PA (2007). The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-α. Mol Endocrinol 21: 2907-2918. (Pubitemid 350223504)
29. Hu, CT, Wu, JR, Chang, TY, Cheng, CC and Wu, WS (2008). The transcriptional factor Snail simultaneously triggers cell cycle arrest and migration of human hepatoma HepG2. J Biomed Sci 15: 343-355.
30. Miyoshi, A, Kitajima, Y, Kido, S, Shimonishi, T, Matsuyama, S, Kitahara, K et al. (2005). Snail accelerates cancer invasion by upregulating MMP expression and is associated with poor prognosis of hepatocellular carcinoma. Br J Cancer 92: 252-258. (Pubitemid 40343137)
31. Chen, S, Zheng, J, Hao, Q, Yang, S, Wang, J, Chen, H et al. (2010). p53-insensitive PUMA down-regulation is essential in the early phase of liver regeneration after partial hepatectomy in mice. J Hepatol 52: 864-871.
32. Zhang, X, Liu, S, Hu, T, Liu, S, He, Y and Sun, S (2009). Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology 50: 490-499.
33. Tao, Z and Zheng, W (1998). The tumor invasion and metastasis in the transplantation of transplanted human hepatocellular carcinoma into nude mice abdominal cavity and orthotopic hepatic tissue. Dier Junyi Daxue Xuebao 16: 54-56.